GlossaryEvidence & ResearchClinical Trial
Evidence & Research

Clinical Trial

Also known as: clinical study · human trial

A clinical trial is a planned study that tests a drug or other intervention in people under a written protocol, usually run in phases 1 through 4.

A clinical trial is research in human volunteers that follows a protocol written in advance: who can join, what they receive and at what dose, what is measured and when, and how the data will be analyzed. In the US, a drug developer must file an Investigational New Drug (IND) application with the FDA before human testing begins, including animal and toxicity data, manufacturing information and the planned study protocols.

Drug trials usually move through phases. According to the FDA, Phase 1 enrolls roughly 20 to 100 healthy volunteers or people with the condition to study safety and dosage; Phase 2 enrolls up to several hundred people with the condition to look at efficacy and side effects; Phase 3 enrolls 300 to 3,000 people to show whether the drug offers a benefit and to catch less common side effects; Phase 4 follows safety in several thousand people after approval. The FDA estimates that about 70% of drugs move from Phase 1 to Phase 2, and about 33% from Phase 2 to Phase 3. Not every trial is randomized: some have a single arm, some are open-label, and the comparison can be a placebo or an existing treatment.

Why it matters

"There's a clinical trial" can mean very different things. A small Phase 1 safety study tells you how a compound behaved in a few people over a short time; it does not show that it works. A Phase 3 randomized trial is built to answer whether it works in a defined population. Under GRADE, the framework many guideline groups use, randomized trials start as high-certainty evidence, but certainty is rated down for risk of bias, imprecision, inconsistency, indirectness (a different dose, route or population than the question asks about) and publication bias.

Many peptides sold for research use have little or no human trial data; BPC-157, for example, rests mostly on animal and cell studies. In DoseCraft's three-lane system, a claim reaches the Clinical lane only when published human data sit behind that specific use, dose range or endpoint. Animal-only data and extrapolation from a related compound do not qualify.

How to read a trial report

  1. Find the phase and the number of participants. A Phase 1 study answers safety and dosing questions, not whether the compound works.
  2. Check who was enrolled (age, sex, health condition) and how closely that matches you.
  3. Note the comparator: placebo, an existing treatment, or none. A single-arm trial cannot separate the drug's effect from change that would have happened anyway.
  4. Find the primary outcome the trial named in advance and read that result before any secondary or subgroup findings.
  5. Check the dose, route and duration actually tested; results do not transfer automatically to a different dose or schedule.
  6. Look for the participant flow: how many enrolled, dropped out and were analyzed. CONSORT 2025, the reporting standard for randomized trials, asks for a 30-item checklist and a flow diagram.

Common mistakes

  • Treating a registered or ongoing trial as a result; registration means a study was planned, not that it found anything.
  • Reading a Phase 1 safety study as proof that a compound works.
  • Borrowing trial results from an approved drug for a different, unapproved peptide that shares a mechanism or part of a name.
  • Quoting a relative benefit ("40% better") without the absolute numbers behind it.
  • Assuming a trial in one population, such as people with type 2 diabetes, answers the question for healthy users.

Sources

  1. ReferenceStep 3: Clinical Research. U.S. Food and Drug Administration, 2018.
  2. GuidelineGRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol, 2011. PMID 21208779.
  3. GuidelineCONSORT 2025 statement: updated guideline for reporting randomised trials. Lancet, 2025. PMID 40245901.

Page updated . How we grade evidence: methodology.

Related Terms

Preclinical Study

A preclinical study tests a compound in cells or tissue (in vitro) or in living animals (in vivo), before or instead of testing it in people.

RCT (Randomized Controlled Trial)

A randomized controlled trial (RCT) assigns people by chance to a treatment or comparison group, so outcome differences can be credited to the treatment.

Three-Lane Evidence System

The three-lane evidence system is DoseCraft's method of labeling each claim by the strength of evidence behind it: Clinical, Expert or Experimental.

Mechanistic Study

A mechanistic study investigates how a compound acts, such as which receptors, pathways or genes it affects, rather than whether it improves health outcomes.

Look up any peptide term inside DoseCraft Pro

The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.

Start Free Trial